| (USD) | Dec 2012 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -2.01M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PVCT returned -26.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +4.8% |
| 1 year | -26.6% |
| 5 years | -3.8% |
| 10 years | -52.3% |
| All-time high | $1,500.00 (May 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PVCT would be worth today ›No. Provectus Biopharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Provectus Biopharmaceuticals, Inc. is part of the Healthcare sector.
Provectus Biopharmaceuticals, Inc. has a market cap of 24.67M USD, based on the latest quote.
